MARK DE CARVALHO: Open Payments
NPI 1306509971 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 8 payments from 7 companies in 2025. Trend: 2023 $37 · 2024 $1,592 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $38 |
| Novo Nordisk Inc | 1 | $34 |
| Amgen Inc. | 1 | $27 |
| Sage Therapeutics, LLC | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Ozempic, KRYSTEXXA, ZURZUVAE, VRAYLAR, NURTEC ODT, Kerendia, UBRELVY, FARXIGA.
Industry payments across CA — which companies pay providers there.
